scispace - formally typeset
A

Aki Komatsu

Researcher at Chiba University

Publications -  14
Citations -  583

Aki Komatsu is an academic researcher from Chiba University. The author has contributed to research in topics: Cancer & Genetic enhancement. The author has an hindex of 10, co-authored 13 publications receiving 508 citations.

Papers
More filters
Journal ArticleDOI

Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma

TL;DR: These data support the contention that serum miR-1246 has strong potential as a novel diagnostic and prognostic biomarker in ESCC, and its releasing mechanism is selective and independent of tissue miRNA abundance.
Journal ArticleDOI

Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma.

TL;DR: Exosome levels may be useful as an independent prognostic factor for ESCC patients and quantification of exosomes in patient plasma as a biomarker for esophageal squamous cell carcinoma was assessed.
Journal ArticleDOI

Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c-myc suppression by interferon-gamma in situ.

TL;DR: IFN‐γ, which induces HLA‐DR antigens on the cell surface, also suppresses c‐myc expression in situ, and is a possible non‐immunological mechanism involved in the better long‐term survival of colorectal cancer patients.
Journal ArticleDOI

Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice.

TL;DR: A combination of direct intratumoral (i.t.) administration of dendritic cells (DCs) and radiation therapy (RT) in mouse squamous cell carcinoma and the functions of gp96, which can enhance systemic antitumor activity, and the mechanism of the abscopal effect are evaluated.
Journal ArticleDOI

ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.

TL;DR: The low expression of ZNF750 was significantly associated with a poor prognosis, and ZNF 750 expression may, therefore, be a reliable prognostic biomarker in ESCC.